Watson To License Takeda's Actos In Patent Deal
Takeda Chemical Industrials Ltd. has agreed to license diabetes medication Actos to rival Watson Pharmaceuticals Inc. and drop a long-running patent infringement case, the generics maker announced Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article